[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576709":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":28,"centralContacts":32,"locations":37,"responsibleParty":67,"collaborators":10,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":10,"eligibilityCriteria":74,"healthyVolunteers":71,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":10,"studyType":81,"phases":10,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Low obstetric risk",null,"i.e., pregnancy with a regular course and not complicated by maternal and\u002For fetal pathology",[13],"Diagnostic Test: Description of the trend of major thyroid ultrasound biometric parameters",{"label":15,"type":10,"description":16,"interventionNames":17},"Hypertyroidism","Group con participants with hypertyroidism",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Hypothyroidism","Group of participants with hypothyroidism",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DIAGNOSTIC_TEST","Description of the trend of major thyroid ultrasound biometric parameters","Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.",[15,19,9],[29],{"name":30,"affiliation":5,"role":31},"Elena Contro, MD","PRINCIPAL_INVESTIGATOR",[33],{"name":30,"role":34,"phone":35,"phoneExt":10,"email":36},"CONTACT","0512143705","elena.contro@aosp.bo.it",[38,52],{"facility":5,"status":39,"city":40,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Bologna","40138","Italy","IT",{"type":45,"coordinates":46},"Point",[47,48],11.33875,44.49381,{"lat":48,"lon":47},[51],{"name":30,"role":34,"phone":35,"phoneExt":10,"email":36},{"facility":53,"status":54,"city":55,"state":42,"zip":10,"country":42,"countryCode":43,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Ospedale Santa Chiara - Trento","NOT_YET_RECRUITING","Trento",{"type":45,"coordinates":57},[58,59],11.12108,46.06787,{"lat":59,"lon":58},[62,66],{"name":63,"role":34,"phone":64,"phoneExt":10,"email":65},"Laura Larcher, MD","+390461903198","laura.larcher2@apss.tn.it",{"name":63,"role":31,"phone":10,"phoneExt":10,"email":10},{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100576709","prenatal-ultrasonographic-assessment-of-fetal-thyroid-in-patients-with-thyroid-pathology-100576709",false,"NCT06788821","Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology","Inclusion Criteria:\n\n* Participants between 14 and 37 gestational weeks, who will be followed for the entire period of pregnancy, up to delivery, at the same enrolling center\n* Obtaining informed consent for participation in the study\n* Maternal age between 18 and 45 years (extremes included)\n* Participants with good understanding of the Italian language\n\nExclusion Criteria:\n\n* Smoking participants\n* Patients with BMI\\>30\n* Absence of correct dating of pregnancy within the first trimester\n* Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth)\n* Twin pregnancy\n* Only for the low obstetric risk group of patients: Fetus with malformative pathology","FEMALE","18 Years","45 Years",{"count":79,"type":80},440,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes in fetuses belonging to women with thyroid disease and women with low obstetric risk (i.e., pregnancy not complicated by maternal and\u002For fetal pathology) between 14 and 37 gestational weeks.\n\nThe main question it aims to answer is:\n\nIs it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?",[84],"Thyroid Disease Pregnancy",[86],"fetal thyroid","2025-01-28",{"date":89,"type":90},"2025-01-29","ACTUAL",{"date":92,"type":90},"2024-06-12",{"date":94,"type":80},"2026-03-01",{"name":5,"class":6},2]